Evidence map›Paper›PMID 39403920›Full record

ArticleThe Journal of clinical investigation2024

Timing of antiretroviral therapy initiation affects intact HIV reservoirs following analytical treatment interruption.

Maegan R Manning, Jana Blazkova, Jesse S Justement, Victoria Shi, Brooke D Kennedy, M Ali Rai, Catherine A Seamon, Kathleen Gittens, Michael C Sneller, Susan Moir and 1 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maegan R ManningLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases and.
Jana BlazkovaLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases and.
Jesse S JustementLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases and.
Victoria ShiLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases and.
Brooke D KennedyLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases and.
M Ali RaiLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases and.
Catherine A SeamonCritical Care Medicine Department, Clinical Center, NIH, Bethesda, Maryland, USA.
Kathleen GittensCritical Care Medicine Department, Clinical Center, NIH, Bethesda, Maryland, USA.
Michael C SnellerLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases and.
Susan MoirLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases and.
Tae-Wook ChunLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV-1HIV InfectionsAdultAnti-HIV AgentsFemaleHumansMaleTime FactorsTreatment InterruptionViral LoadAnti-HIV AgentsAIDS/HIVDrug therapy

Identifiers

PMID39403920
PMCPMC11473155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.